N3-C4-NHS ester

CAS No. 478801-48-8

N3-C4-NHS ester( —— )

Catalog No. M26990 CAS No. 478801-48-8

N3-C4-NHS ester is a non cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 73 Get Quote
10MG 104 Get Quote
25MG 173 Get Quote
50MG 255 Get Quote
100MG 377 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    N3-C4-NHS ester
  • Note
    Research use only, not for human use.
  • Brief Description
    N3-C4-NHS ester is a non cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
  • Description
    N3-C4-NHS ester is a non cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    COMT
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    478801-48-8
  • Formula Weight
    240.219
  • Molecular Formula
    C9H12N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [N-]=[N+]=NCCCCC(=O)ON1C(=O)CCC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yamaki F, et, al. Effects of Catecholamine Metabolites on Beta-Adrenoceptor-Mediated Relaxation of Smooth Muscle: Evaluation in Mouse and Guinea-Pig Trachea and Rat Aorta. Biol Pharm Bull. 2020;43(3):493-502.
molnova catalog
related products
  • Bacopaside V

    Bacopaside V is a natural product.

  • BODIPY 493/503

    BODIPY 493/503 is a lipophilic fluorescent probe with Ex/Em of 493/503 nm. BODIPY 493/503 localizes to polar lipids and can be used to label cellular neutral lipid contents and for live and fixed cell applications.

  • Cancer-Targeting Com...

    Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among others.